Shares of Neovasc Inc. (NASDAQ:NVCN) jumped 1.50% to reach at $0.51 during previous trading session. The company has experienced volume of 440,724 shares while on average the company has a capacity of trading 3.07M share.
Shares of the Canadian medical device maker Neovasc Inc (NASDAQ: NVCN) were rallying Tuesday following the circulation of a document with a patent abstract it filed with the U.S. Patent and Trademark Office.
The patent abstract pertains to the methods and apparatus for loading a prosthesis onto a delivery system. This relates to the company’s Tiara prosthetic valve, which replaces the mitral valve of the heart when delivered through the apex of the heart.
“One or more actuators on the first housing may be actuated radially inward to selectively compress a discrete portion of the prosthesis disposed in the central bore,” the document said.
A patent abstract is a short summary of the product and/or method for which a company is seeking to obtain a patent. The USPTO mandates that all non-provisional patent applications should be presented with an abstract.
It is part of the patent application and is 150 words or less.
The USPTO can reject an abstract if it is not prepared in line with guidelines.The patent process is a lengthy one, and any interruption such as the rejection of an abstract will only serve to elongate the process.
Neovasc shares were up 6.17 percent at 50 cents at the time of publication Tuesday.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer (the “Reducer”), for the treatment of refractory angina, which is not presently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara™, for the transcatheter treatment of mitral valve disease, which is presently under clinical investigation in the United States, Canada and Europe.
Neovasc Inc. (NASDAQ:NVCN) holds the market capitalization of $12.52M along with 24.98M outstanding shares. During the last trade, stock’s minimum price has been reached out at $0.50 while the maximum trading price moved at $0.51. Currently the stock price is moving 36.75% off from the highest level of twelve months and -88.89% above from twelve months low. Neovasc Inc. (NASDAQ:NVCN) marked 52-week highest price level of $4.58 on N/A and 52-week lowest price level of $0.37 on N/A.
As of current trade, Neovasc Inc. (NASDAQ:NVCN) has shown weekly upbeat performance of 2.89%. Its six months performance indicated a bearish -35.83% movement while its yearly performance reflected a negative trend of -85.56%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -16.88%. Shares of Neovasc Inc. (NASDAQ:NVCN) currently have an ABR of 2.00, derived from a total of 3 opinions. The company’s price sits 4.42% above from its 50-day moving average of $0.4994 and -56.67% below from the stock’s 200-day moving average of $0.5804. The company has Relative Strength Index (RSI 14) of 54.95 along with Average True Range (ATR 14) of 0.05. Its weekly and monthly volatility is 6.57%, 9.88% respectively. The company’s beta value is at 0.
Neovasc Inc. currently has a PEG ratio of 0 where as its P/E ratio is 0. The company’s price to sales ratio for trailing twelve months is 6.28 and price to book ratio for most recent quarter is 0, whereas price to cash per share for the most recent quarter is 0. Neovasc Inc. (NASDAQ:NVCN)’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 0 along with current ratio for most recent quarter of 0. Total debt to equity ratio of the company for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. Neovasc Inc. (NASDAQ:NVCN) has a Return on Assets of 0. The company currently has a Return on Equity of 0 and Return on Investment of 0.